-
by Jamie Doggett-
Aug 16, 2016
This article was written and researched by Jamie Doggett and Junell Harrington , Research Analysts at CREATION In 2013 and 2014 Gilead Sciences released two new drugs listed for the treatment of Hepatitis C (HCV): Harvoni (ledipasvir–sofosbuvir)...
-
by Daniel Ghinn-
Aug 9, 2016
In my last article for this column, I looked at how doctors were talking about the EU referendum in the final days before the UK went to the polls. In the few weeks that have passed...
-
by Will Moore-
Aug 4, 2016
This post is part of an ongoing study of emergent social websites, and their role in healthcare professional conversation. To view other posts in the series, please click here. In the previous articles in this series,...
-
by Will Moore-
Jul 27, 2016
The past decade has seen innovation and disruption spread across sectors as diverse as banking, tourism and retail, with long established players overtaken by plucky young upstarts doing things a different way. Alongside these startup businesses...
-
by Will Moore-
Jul 20, 2016
This post is part of an ongoing study of emergent social websites, and their role in healthcare professional conversation. To view other posts in the series, please click here. The focus for this article is to...
This article was written and researched by Jamie Doggett and Junell Harrington , Research Analysts at CREATION In 2013 and 2014 Gilead Sciences released two new drugs listed for the treatment of Hepatitis C (HCV): Harvoni (ledipasvir–sofosbuvir)...
In my last article for this column, I looked at how doctors were talking about the EU referendum in the final days before the UK went to the polls. In the few weeks that have passed...
This post is part of an ongoing study of emergent social websites, and their role in healthcare professional conversation. To view other posts in the series, please click here. In the previous articles in this series,...
The past decade has seen innovation and disruption spread across sectors as diverse as banking, tourism and retail, with long established players overtaken by plucky young upstarts doing things a different way. Alongside these startup businesses...
This post is part of an ongoing study of emergent social websites, and their role in healthcare professional conversation. To view other posts in the series, please click here. The focus for this article is to...
